Health Law

Bovenberg handles a wide variety of contentious and non-contentious issues relating to the healthcare sector, including healthcare insurance and the provision of primary and secondary care by independent healthcare centres. Specifically, he counsels on all legal aspects associated with medical innovations and regenerative medicine in the area of tissue-engineering and biobanking. Being a member of a number of national and international oversight bodies secures him readily access to and first hand experience with the rapid and cutting edge developments in this area.

Pharmaceutical Law

As lead-counsel to a number of major multinational companies, Bovenberg has gained extensive experience in all regulatory matters governing the various stages of the development and marketing of pharmaceuticals, medical devices and biotechnology products. Apart from drafting clinical trial agreements and advising on related privacy issues, he has handled and supervised complex litigation involving the marketing authorisation, the pricing, the reimbursement and the marketing of prescription drugs, medical devices and biomaterials.

Bio-Technology Transfer

Representing, alternatively, the universities, start-up companies, big pharma or venture capitalists involved, Bovenberg has regularly counselled on all legal issues associated with the transfer of technology in the area of biomedicine. He has in-depth knowledge of both the key elements and the fine print that goes into designing and negotiating successful university-industry collaboration agreements, material transfer agreements, licensing agreements and all ancillary agreements.